Press/Media
- 1 - 25 out of 101 results
Search results
-
-
Vaccine Trouble Escalates Amid Postponements and Finger-Pointing
28/01/21
1 item of Media coverage
Press/Media: Expert Comment
-
Prédire la nocivité des nanoparticules pour mieux les utiliser.
18/03/19
1 Media contribution
Press/Media: Expert Comment
-
Reports Outline COVID-19 Study Results from University of Namur (An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort)
Jean-Michel Dogne, Jonathan Douxfils, Julien FAVRESSE & Constant Gillot
5/04/24
1 item of Media coverage
Press/Media: Expert Comment
-
-
Agenda - CHMP agenda of the 16-19 August 2021 meeting: written procedure
16/08/21
1 item of Media coverage
Press/Media: Expert Comment
-
-
Agenda of the PRAC meeting 9-12 January 2023
9/01/23
1 item of Media coverage
Press/Media: Expert Comment
-
The Pfizer vaccine may soon be authorized from the age of 12: what is the point of vaccinating children who are not at risk?
5/05/21
1 item of Media coverage
Press/Media: Expert Comment
-
Data on COVID-19 Detailed by Researchers at University of Namur (Clinical Performance Evaluation of the Fluorecare? Sars-cov-2 & Influenza A/b & Rsv Rapid Antigen Combo Test In Symptomatic Individuals)
Jean-Michel Dogne, Jonathan Douxfils, Julien FAVRESSE & Constant Gillot
28/04/23
1 item of Media coverage
Press/Media: Expert Comment
-
Researchers analyse the toxicity of nanomaterials.
21/02/18
1 Media contribution
Press/Media: Expert Comment
-
The NNC studies the toxicity of nanomaterials in paint
9/02/18
1 Media contribution
Press/Media: Expert Comment
-
Les Éclaireurs: Hématologie, Marionette & Bioluminescence
14/07/18
1 Media contribution
Press/Media: Research
-
is Belgium “behind” in the vaccination process?
2/12/20
1 item of Media coverage
Press/Media: Expert Comment
-
Findings from University of Liege in the Area of Technology Reported (Advances In Analytical Technologies Detecting and Characterizing Noncovalent Interactions for Fragment-based Drug Discovery)
4/09/23
1 item of Media coverage
Press/Media: Expert Comment
-
Study reveals nanomaterials in paints to be non-toxic
15/02/18
1 Media contribution
Press/Media: Expert Comment
-
Truth or Fake: Magnetism after a Covid-19 vaccine in Belgium? An expert explains
1/07/21
2 items of Media coverage
Press/Media: Expert Comment
-
The campaign is launched, the figures are going up: should we be revaccinated against Covid-19?
7/10/22
1 item of Media coverage
Press/Media: Expert Comment
-
Does the vaccine reduce the risk of coronavirus transmission? Here are the results of a study by Sciensano
30/08/21
1 item of Media coverage
Press/Media: Expert Comment
-
“If all goes well, a vaccine could be available at the end of January”
26/08/20
1 item of Media coverage
Press/Media: Expert Comment
-
-
E.U. to Embark on a High-Stakes Coronavirus Vaccine Rollout
21/12/20
2 items of Media coverage
Press/Media: Expert Comment
-
Does the vaccine reduce the risk of coronavirus transmission? Here are the results of a study by Sciensano
29/08/21
1 item of Media coverage
Press/Media: Expert Comment
-
New Findings from University of Namur in Tuberculosis Provides New Insights (Targeting the Phosphoserine Phosphatase Mtserb2 for Tuberculosis Drug Discovery, an Hybrid Knowledge Based /fragment Based Approach)
24/05/23
1 item of Media coverage
Press/Media: Expert Comment
-
Agenda of the CHMP meeting 12-15 December 2022
12/12/22
1 item of Media coverage
Press/Media: Expert Comment